FBLN2 and gastric cancer: The results of our rescue experiments demonstrated that the inhibitor perifosine and activator SC79 effectively counteracted the impacts of ITGBL1 overexpression and knockdown, respectively, on FBLN2 expression, resistance to anoikis, and metastasis in GC.